Wenger Vieli as Swiss legal advisor for NLS Pharmaceutics

NLS Pharmaceutics, a Swiss clinical-stage biopharmaceutical company, has entered into a definitive agreement with BVF PARTNERS to raise aggregate gross proceeds of up to USD 30.0 million in a two-tranche private placement. 

The net proceeds will enable the Swiss clinical-stage biopharmaceutical company to advance the ongoing clinical development of its products and further support business development and licensing activities. 

Wenger Vieli has acted as Swiss legal advisor to NLS Pharmaceutics on all Swiss legal aspects in connection with the PIPE transaction. The team was led by Pascal Honold (partner, m&a/vc/pe) and included Kevin Wilhelm Vangehr (associate, m&a/vc/pe), Alessa Waibel (associate, financial services), Andrea Christen (associate, m&a/vc/pe) and Mark P. Stocker (associate, notarial services).

Wenger Vieli as Swiss legal advisor for NLS Pharmaceutics



Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram